Daily News Analysis

Medicines Patent Pool Agreement for Leukaemia

stylish_lining
  • Three firms with headquarters in India have inked sub-licence agreements with the Medicines Patent Pool (MPP), a United Nations-backed organisation, to make some cancer medications more affordable and available to patients.

  • These agreements permit the manufacturing of generic versions of the cancer medication Nilotinib, which is primarily used to treat Chronic Myeloid Leukaemia (CML), in a number of nations.

  • The licence permits the supply of generic versions of nilotinib in India, seven middle-income countries, and 44 territories, subject to local regulatory approval.

    About medicines patent pool

  • The MPP is a group supported by the UN that works to improve low- and middle-income nations' access to life-saving medications.

  • The MPP strives to remove obstacles brought about by patents and intellectual property rights that restrict access to and the cost of important medications.

  • To enable the creation of generic versions of proprietary medications, the MPP bargains voluntary licencing agreements with pharmaceutical firms.

  • The MPP grants licences to qualifying manufacturers, allowing them to create and distribute low-cost generic medications in low- and middle-income nations.

    Need

  • The MPP's collaborative approach is required in order to solve global health issues and advance access to medications. The MPP works in partnership with governments, nonprofit organisations, civil society organisations, and pharmaceutical firms.

  • Priority Diseases: The MPP focuses on diseases like HIV/AIDS, TB, hepatitis C, and other priority areas where access to cheap pharmaceuticals is essential.

  • Sustainable Supply of Generic Drugs: By entering into licencing agreements, the MPP maintains a steady supply of generic drugs with high quality standards, fostering market competition and increasing the range of available therapies.

  • Enhancing Access to Life-Saving Treatments and Lowering the Burden of High medication Costs: The MPP's work improves health outcomes and saves lives by lowering the burden of high medication costs.

    How do you define chronic myeloid leukaemia (CML)?

  • It belongs to the category of leukaemia, a blood-cell malignancy that affects both the bone marrow and the blood. Other varieties include Chronic Lymphocytic Leukaemia (CLL), Acute Myeloid Leukaemia (AML), and Acute Lymphoblastic Leukaemia (ALL).

  • Myeloid cells, aberrant white blood cells, which are its defining feature, develop out of control.

  • CML usually advances slowly, and the chronic stage is when it is frequently identified.

  • Blood tests and a bone marrow analysis are frequently used to make the diagnosis of CML.

Visakhapatnam Declaration on e-Governance

The Visakhapatnam Declaration on e-Governance marks a significant step in the development of digital governance in India, emphasizing inclusive, transparent, and citizen-centric practices. Adopted
Share It

Defamation in India

Recently, a Supreme Court judge raised concerns about the increasing misuse of defamation laws by political figures and private individuals to settle personal and political disputes. The judge sug
Share It

Simultaneous Elections

India's ongoing debate about simultaneous elections or the One Nation, One Election concept has gained momentum, with experts like Arvind Panagariya, Chairman of the 16th Finance Commission, e
Share It

Shanghai Cooperation Organisation (SCO) 2025 Summit

The 2025 SCO Heads of State Summit was held in Tianjin, China, marking a significant moment for the organization’s expanding role on the global stage. Key Highlights: Terrorism:
Share It

Production Gap Report 2025

The Production Gap Report 2025 reveals a troubling trend: many countries are planning to increase fossil fuel production well beyond the levels needed to limit global warming to 1.5°C as per t
Share It

India's Roadmap for Fusion Power

India's Institute for Plasma Research (IPR) in Gandhinagar has recently proposed a comprehensive roadmap for the development of fusion power, marking a significant leap towards harnessing fusi
Share It

Dhvani Missile

India's Defence Research and Development Organisation (DRDO) is on the verge of a historic milestone with the upcoming test of Dhvani, a next-generation hypersonic missile that is set to prope
Share It

Global Innovation Index (GII) 2025

India has made remarkable strides in the field of innovation, moving up from 48th position in 2020 to 38th in 2025 among 139 global economies, according to the World Intellectual Property Organiza
Share It

Critical Minerals

India’s first auction of deep-sea blocks for the extraction of critical minerals has been delayed indefinitely after receiving a poor response from bidders. This auction was expected to be a
Share It

CAG Report on States’ Fiscal Health

The Comptroller and Auditor General of India (CAG) has released its first decadal analysis on the fiscal health of 28 Indian states, revealing significant concerns over the increasing public debt.
Share It

Newsletter Subscription


ACQ IAS
ACQ IAS